Death, Sudden, Cardiac

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
1 program
Defibrillator, Dual Chamber ; ImplantableN/A1 trial
Active Trials
NCT00478933Completed1,223Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rhythm PharmaceuticalsDefibrillator, Dual Chamber ; Implantable

Clinical Trials (1)

Total enrollment: 1,223 patients across 1 trials

NCT00478933Rhythm PharmaceuticalsDefibrillator, Dual Chamber ; Implantable

DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.

Start: Feb 2007Est. completion: Dec 20121,223 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space